tried telehealth for 15 weeks. here is what happened.
I have had 5 orders now and I keep a table, so here is the honest summary rather than a vibe. Material has been consistent. Communication has not. Shipping has varied by about 10 days on nominally the same lane, which matters more in summer than in February. The independent number came back 93.7% against a claimed…
Yeah, 503A and 503B are different regulatory animals.
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
state board rules differ, say which state
telehealth prescriber models exist, pricing differs by state
no pharmacy referral codes, naming is fine, recruiting is not
Rodent data is rodent data.
Adding to this: shortage list is doing more work than the comment implies.
the shortage list is temporary, it ends and compounding becomes illegal again
regulatory claims need a citation to the actual rule, not interpretation
Slight fix: the number was 98.7, not 99.3. Decimal point, but a fairly consequential one.
The telehealth + compounding combo cost state board plus 16% markup. Not cheap but covered by insurance depending on state.